Peptide Libraray

A4K14-citropin1.1-Sp2

General Information

DRACP ID DRACP05889

Peptide Name A4K14-citropin1.1-Sp2

Sequence GLFAⓍIKKⓍASVIKGL

Sequence Length 16

UniProt ID Not available

PubChem CID Not available

Origin Synthetic

Type Synthetic peptide

Classification

Cancer targeted peptides Stapled Peptides Membrane-targeted

Activity Information

Cell Line	Disease	Cancer Classified	Activity	Assay	Testing Time	Literature
C4-2B	Prostate carcinoma	Carcinoma	IC50=10.14 μM	CCK-8 assay	96 h	1
A549	Lung adenocarcinoma	Carcinoma	IC50=12.55 μM	CCK-8 assay	96 h	1
U87	Glioblastoma	Blastoma	IC50=14.76 μM	CCK-8 assay	96 h	1
MCF-7	Invasive breast carcinoma of no special type	Carcinoma	IC50=12.65 μM	CCK-8 assay	96 h	1

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Nature Anticancer

Structure Information

PDB ID Not available

Predicted Structure Not available

Helicity 66.1

Linear/Cyclic Cyclic (Stapled)

Disulfide/Other Bond Stapled: Ⓧ are cross-linked by hydrocarbon stapling

N-terminal Modification Acetylation

C-terminal Modification Amidation

Other Modification Ⓧ=(S)-2-(4-pentenyl)alanine

Chiral L

Physicochemical Information

Formula C69H117N17O14

Absent amino acids CDEHMNPQRTWY

Common amino acids K

Mass 167654

Pl 11.1

Basic residues 3

Acidic residues 0

Hydrophobic residues 8

Net charge 3

Boman Index 1215

Hydrophobicity 86.88

Aliphatic Index 128.13

Half Life
/

Extinction Coefficient cystines 0

Absorbance 280nm 0

Polar residues 3

Amino acid distribution

Literature Information

Literature 1

Pubmed ID 33363118

Title Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides

Doi 10.3389/fchem.2020.616147

Year 2020

Patent

Patent ID Not available

Patent Title Not available

Other Iinformation Not available

Other Published ID Not available